Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Leopoldo Paolo Pucillo is active.

Publication


Featured researches published by Leopoldo Paolo Pucillo.


Journal of Immunology | 2002

Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis.

Cristiana Gioia; Chiara Agrati; Rita Casetti; Cristiana Cairo; Giovanna Borsellino; Luca Battistini; Giorgio Mancino; Delia Goletti; Vittorio Colizzi; Leopoldo Paolo Pucillo; Fabrizio Poccia

In humans, the circulating pool of mycobacteria-reactive Vγ9Vδ2+ T cells is expanded with age and may contribute to Mycobacterium tuberculosis immunosurveillance. We observed that two subsets of Vγ9Vδ2+ T cells could be identified on the basis of CD27 expression in immunocompetent adults, showing that functionally differentiated γδ T cells have lost CD27 expression. In contrast, the CD27−CD45RA−Vγ9Vδ2+ T cell subset of effector cells was absent in cord blood cells from healthy newborns and lacking in the peripheral blood from HIV-infected patients. Moreover, circulating Vγ9Vδ2+ T cell effectors were significantly reduced in patients with acute pulmonary tuberculosis, resulting in a reduced frequency of IFN-γ-producing cells after stimulation with nonpeptidic mycobacterial ligands. These observations indicate that monitoring and boosting γδ T cell effectors could be clinically relevant both in immunocompromised hosts and during active tuberculosis disease.


Gut | 2011

Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins

Carmine Mancone; Corinna Steindler; Laura Santangelo; Giacoma Simonte; Chrysoula Vlassi; Maria Antonella Longo; Gianpiero D'Offizi; Cristina Di Giacomo; Leopoldo Paolo Pucillo; Laura Amicone; Marco Tripodi; Tonino Alonzi

Background/aims The life cycle of hepatitis C virus (HCV) is intimately linked to the lipid metabolism of the host. In particular, HCV exploits the metabolic machinery of the lipoproteins in several steps of its life cycle such as circulation in the bloodstream, cell attachment and entry, assembly and release of viral particles. However, the details of how HCV interacts with and influences the metabolism of the host lipoproteins are not well understood. A study was undertaken to investigate whether HCV directly affects the protein composition of host circulating lipoproteins. Methods A proteomic analysis of circulating very low-, low- and high-density lipoproteins (VLDL, LDL and HDL), isolated from either in-treatment naïve HCV-infected patients or healthy donors (HD), was performed using two-dimensional gel electrophoresis and tandem mass spectrometry (MALDI-TOF/TOF). The results obtained were further investigated using in vitro models of HCV infection and replication. Results A decreased level of apolipoprotein A-I (apoA-I) was found in the LDL fractions of HCV-infected patients. This result was confirmed by western blot and ELISA analysis. HCV cellular models (JFH1 HCV cell culture system (HCVcc) and HCV subgenomic replicons) showed that the decreased apoA-I/LDL association originates from hepatic biogenesis rather than lipoprotein catabolism occurring in the circulation, and is not due to a downregulation of the apoA-I protein concentration. The sole non-structural viral proteins were sufficient to impair the apoA-I/LDL association. Functional evidence was obtained for involvement of apoA-I in the viral life cycle such as RNA replication and virion production. The specific siRNA-mediated downregulation of apoA-I led to a reduction in both HCV RNA and viral particle levels in culture. Conclusions This study shows that HCV induces lipoprotein structural modification and that its replication and production are linked to the host lipoprotein metabolism, suggesting apoA-I as a new possible target for antiviral therapy.


Antimicrobial Agents and Chemotherapy | 2010

Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones

Maria Rosalia Pasca; Giulia Degiacomi; Ana Luisa de Jesus Lopes Ribeiro; Francesca Zara; Patrizia De Mori; Beate Heym; Maurizio Mirrione; Roberto Brerra; Laura Pagani; Leopoldo Paolo Pucillo; Panajota Troupioti; Vadim Makarov; Stewart T. Cole; Giovanna Riccardi

ABSTRACT The new antitubercular drug candidate 2-[2-S-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (BTZ043) targets the DprE1 (Rv3790) subunit of the enzyme decaprenylphosphoryl-β-d-ribose 2′-epimerase. To monitor the potential development of benzothiazinone (BTZ) resistance, a total of 240 sensitive and multidrug-resistant Mycobacterium tuberculosis clinical isolates from four European hospitals were surveyed for the presence of mutations in the dprE1 gene and for BTZ susceptibility. All 240 strains were susceptible, thus establishing the baseline prior to the introduction of BTZ043 in clinical trials.


Journal of Leukocyte Biology | 2004

Dendritic cells derived from BCG-infected precursors induce Th2-like immune response.

Angelo Martino; Alessandra Sacchi; Nunzia Sanarico; Francesca Spadaro; Carlo Ramoni; Antonio Ciaramella; Leopoldo Paolo Pucillo; Vittorio Colizzi; Silvia Vendetti

Human monocytes can differentiate into dendritic cells (DCs) according to the nature of environmental signals. We tested here whether the infection with the live tuberculosis vaccine bacillus Calmette‐Guerin (BCG), which is known to be limited in preventing pulmonary tuberculosis, modulates monocyte and DC differentiation. We found that monocytes infected with BCG differentiate into CD1a– DCs (BCG‐DCs) in the presence of granulocyte macrophage‐colony stimulating factor and interleukin (IL)‐4 and acquired a mature phenotype in the absence of maturation stimuli. In addition, BCG‐DCs produced proinflammatory cytokines (tumor necrosis factor α, IL‐1β, IL‐6) and IL‐10 but not IL‐12. BCG‐DCs were able to stimulate allogeneic T lymphocytes to a similar degree as DCs generated in the absence of infection. However, BCG‐DCs induced IL‐4 production when cocultured with human cord‐blood mononuclear cells. The induction of IL‐4 production by DCs generated by BCG‐infected monocytes could explain the failure of the BCG vaccine to prevent pulmonary tuberculosis.


The Journal of Infectious Diseases | 2002

Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vγ9Vδ2 T cells in chronically infected patients undergoing structured treatment interruption

Federico Martini; Delia Goletti; Stefania Carrara; Donatella Vincenti; Gianpiero D’Offizi; Chiara Agrati; Giuseppe Ippolito; Vittorio Colizzi; Leopoldo Paolo Pucillo; Carla Montesano

T cells expressing Vgamma9Vdelta2 display lytic and proliferative responses against human immunodeficiency virus (HIV)-infected cells and release antiviral soluble factors. Chronic HIV-positive patients have deep changes in the composition and function of the circulating gammadelta T cell pool that are restored by highly active antiretroviral therapy (HAART). gammadelta T cells were analyzed during the rapid plasma HIV RNA rebound in HIV-infected patients undergoing structured treatment interruption (STI). A loss in circulating Vgamma9Vdelta2 T cells was observed, indicating that acute HIV replication may influence Vgamma9Vdelta2 homeostasis. These cells were lost among CD45RA(-)CD27(-) Vgamma9Vdelta2 T cell effectors, and a significant unresponsiveness, measured as antigen-driven interferon-gamma production, was observed during STI. After HAART resumption and consequent inhibition of HIV replication, Vgamma9Vdelta2 T cell reactivity was restored both quantitatively and functionally. These observations indicate that Vgamma9Vdelta2 T cells are activated early after active HIV replication but are rapidly lost when viremia is not controlled.


The Journal of Infectious Diseases | 2002

Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages.

Antonio Ciaramella; A. Cavone; Marilina B. Santucci; Massimo Amicosante; Angelo Martino; Giovanni Auricchio; Leopoldo Paolo Pucillo; Vittorio Colizzi; Maurizio Fraziano

Mycobacterium tuberculosis (MTB) can induce apoptosis in monocytes/macrophages both in vitro and in vivo, and this phenomenon is associated with mycobacterial survival. The present study addresses the possibility that apoptotic and inflammatory pathways could coexist through a caspase-1-mediated mechanism. In this context, a caspase-1 inhibitor (YVAD), but not caspase-3 (DEVD) or caspase-4 (LEVD) inhibitors, was able to strongly inhibit MTB-induced apoptosis. Moreover, caspase-1 activity was confirmed by the increased maturation of interleukin (IL)-1beta. Of interest, IL-1beta and tumor necrosis factor (TNF)-alpha were produced massively in the course of infection, and both were inhibited by YVAD pretreatment. To determine whether TNF-alpha was produced actively by apoptotic cells, the intracytoplasmatic cytokine content and apoptotic phenotype were analyzed at the single-cell level. Results showed a progressive increase of TNF-alpha production in annexin V-positive cells. These results indicate that MTB-induced apoptosis is associated with proinflammatory cytokine production.


Mycoses | 2008

Identification of clinically relevant yeast species by DNA sequence analysis of the D2 variable region of the 25–28S rRNA gene

Lorenza Putignani; Maria Grazia Paglia; Eugenio Bordi; Elena Nebuloso; Leopoldo Paolo Pucillo; Paolo Visca

Clinically relevant yeasts are conventionally identified by a combination of phenotypic tests, which occasionally provide ambiguous results for atypical isolates or uncommon species. In this study, we evaluate a direct polymerase chain reaction‐sequencing method, which exploits sequence divergence in the hypervariable D2 region of the large subunit of the 25–28S ribosomal RNA (rRNA) gene for identification of facultative pathogenic asco‐ and basidiomycota. A panel of 53 yeasts, including 40 clinical isolates and 13 reference strains representative of some clinically relevant taxa, was investigated by combining standard phenotypic tests with commercial identification systems (RapID, API 20C AUX), and results were compared with the taxonomic allocations inferred by D2 sequence analysis. Species‐level resolution was achieved for almost all (52/53) strains by combining internet‐based D2 sequence homology (BLAST and FASTA) searches in free‐access synchronised databases with phylogenetic analysis. The phylogenetic information carried by the short D2 sequence substantiates a pattern of molecular evolution, which is similar to that inferred from analysis of the larger D1/D2 region, and consistent with previously published 25–28S rRNA phylogenetic architectures of facultative pathogenic yeast, including recently identified species. Inconsistency between conventional and molecular identification results was observed for 11/53 strains, likely on account of the ambiguous interpretation of phenotypic tests.


Journal of Clinical Microbiology | 2002

Simple and Reliable Method for Detection and Genotyping of Hepatitis C Virus RNA in Dried Blood Spots Stored at Room Temperature

Mariacarmela Solmone; Enrico Girardi; Francesco Costa; Leopoldo Paolo Pucillo; Giuseppe Ippolito; Maria Rosaria Capobianchi

ABSTRACT We describe a simple, sensitive, and reproducible method for using whole blood collected onto filter paper (dried blood spots) for detection and genotyping of hepatitis C virus RNA that can be useful in large field studies, particularly in settings where collection, preparation, storage, and shipment of samples at controlled temperature can be difficult.


AIDS | 2002

Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption.

Gianpiero D'Offizi; Carla Montesano; Chiara Agrati; Cristiana Gioia; Massimo Amicosante; Simone Topino; Pasquale Narciso; Leopoldo Paolo Pucillo; Giuseppe Ippolito; Fabrizio Poccia

Objective: The influence of structured treatment interruption on effector/memory CD8 T cell dynamics was analysed in chronic HIV-infected patients showing a rapid or delayed viral rebound. Design: Structured treatment interruption consisted of at least one month of discontinuation, followed by highly active antiretroviral therapy (HAART) resumption. Two groups of HIV structured treatment interruption patients were selected on the basis of plasma viral HIV-RNA value (> 30 000 copies/ml, branched DNA): group A (n = 14), patients with a rapid viral rebound (within one month) and group B (n = 6), patients with a delayed or no viral rebound (after a minimum of 4 months). Methods: A clinical and immunological follow-up was performed at HAART suspension (t 0), one month from suspension (t 1), at HAART resumption (t 2), and 30 days from resumption (t 3). Results: A sustained viral rebound was observed in group A patients, showing a rapid expansion of circulating CD8 T lymphocytes. In this group, the frequencies of CD8 T cells releasing IFN-γ after mitogen-induced or Gag-specific stimulation were highly increased after HAART discontinuation. Nevertheless, these CD8 T lymphocytes were mainly composed of pre-terminally differentiated cytotoxic T lymphocytes (CTL) expressing a CCR7− CD27+/− CD45RA− phenotype and a reduced amount of perforin. In contrast, group B patients showed no significant changes in immunological parameters during a prolonged drug-free period. Conclusion: These data indicate that monitoring CD8 T cell dynamics during structured treatment interruption could be clinically relevant, and new therapeutic strategies should aim qualitatively to restore CTL effector functions.


Biochemical and Biophysical Research Communications | 2010

Flavohemoglobin and nitric oxide detoxification in the human protozoan parasite Giardia intestinalis

Daniela Mastronicola; Fabrizio Testa; Elena Forte; Eugenio Bordi; Leopoldo Paolo Pucillo; Paolo Sarti; Alessandro Giuffrè

Flavohemoglobins (flavoHbs), commonly found in bacteria and fungi, afford protection from nitrosative stress by degrading nitric oxide (NO) to nitrate. Giardia intestinalis, a microaerophilic parasite causing one of the most common intestinal human infectious diseases worldwide, is the only pathogenic protozoon as yet identified coding for a flavoHb. By NO amperometry we show that, in the presence of NADH, the recombinant Giardia flavoHb metabolizes NO with high efficacy under aerobic conditions (TN=116+/-10s(-1) at 1microM NO, T=37 degrees C). The activity is [O(2)]-dependent and characterized by an apparent K(M,O2)=22+/-7microM. Immunoblotting analysis shows that the protein is expressed at low levels in the vegetative trophozoites of Giardia; accordingly, these cells aerobically metabolize NO with low efficacy. Interestingly, in response to nitrosative stress (24-h incubation with 5mM nitrite) flavoHb expression is enhanced and the trophozoites thereby become able to metabolize NO efficiently, the activity being sensitive to both cyanide and carbon monoxide. The NO-donors S-nitrosoglutathione (GSNO) and DETA-NONOate mimicked the effect of nitrite on flavoHb expression. We propose that physiologically flavoHb contributes to NO detoxification in G. intestinalis.

Collaboration


Dive into the Leopoldo Paolo Pucillo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pasquale Narciso

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Giuseppe Ippolito

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Chiara Agrati

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Fabrizio Poccia

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Gianpiero D'Offizi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Federico Martini

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Eugenio Bordi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge